Cingulate Therapeutics
6 clinical trials · Sponsor
◉ Watch Cingulate Therapeutics
| Record | Firm | Date |
|---|---|---|
| In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) (NCT07119073) | Cingulate Therapeutics | 2024-10-31 |
| Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 (NCT05286762) | Cingulate Therapeutics | 2023-08-01 |
| Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 (NCT05924594) | Cingulate Therapeutics | 2023-07-31 |
| Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. (NCT05631626) | Cingulate Therapeutics | 2022-12-29 |
| Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects (NCT04449250) | Cingulate Therapeutics | 2022-09-14 |
| CTx-1301 Comparative Bioavailability Study (NCT04138498) | Cingulate Therapeutics | 2019-12-06 |
Track Cingulate Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.